Founded in 2011, the Moleculera test panel was developed by company co-founder Madeleine Cunningham, Ph.D., a professor at the University of Oklahoma Health Sciences Center who serves as the company's Chief Scientific Officer. Over the past decade, Dr. Cunningham and her laboratory at OU have developed and performed a unique panel of autoimmune identification and cell stimulation tests to aid the physician in the determination of a patient's PANDAS and PANS diagnosis. Currently the Cunningham panel is composed of five individual tests.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 10/03/13 | $1,840,000 |
i2E SeedStep Angels | undisclosed |
